Central European Journal of Medicine

, Volume 6, Issue 4, pp 456–462 | Cite as

High-risk hpv infection in sexually active and non active young women

  • Zana Bumbuliene
  • Jonas Alisauskas
  • Agne Sepetiene
Research Article
  • 62 Downloads

Abstract

To determine the prevalence of high-risk HPV infection before first vaginal intercourse and after initiation of sexual activity in 14-22 years old girls, to find which HPV types occur most commonly. During the gynecologic exam cervical swabs were collected. Specimens were tested using Hybrid Capture 2 DNA test. In positive samples digene HPV genotyping test was performed. Subjects included 264 women, of whom 169 (64.0%) reported previous sexual activity and 95 (36.0%) had not yet had vaginal intercourse. There were 43 cases (16.3%) of high risk HPV, with 39 cases in those reporting sexual activity and 4 in virgins. Single strain HPV infection was detected in 62.8%, two strains in 23.2%, and three strains in 14.0% of subjects. HPV-16 was the most common type (20.9%), next more prevalent types were 18, 56, 31, 33 and 59. HPV-16 or HPV-18 were detected in 39.5% of the subjects. Not a single case was identified containing both types. The prevalence of high-risk HPV is common in sexually active young Lithuanian women. HPV were found in a small percentage of girls who had never had vaginal intercourse. The prevalence of types 16 and 18 among Lithuanian women was higher than in international data.

Keywords

High-risk HPV prevalence Virgins Young women 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    Cogliano V., Baan R., Straif K., et al., WHO International Agency for Research on Cancer: Carcinogenicity of human papillomaviruses, Lancet Oncol., 2005, 6(4), 204PubMedCrossRefGoogle Scholar
  2. [2]
    Bosch F.X., Lorincz A., Munoz N., et al., The causal relation between human papillomavirus and cervical cancer, J Clin Pathol., 2002, 55, 244–265PubMedCrossRefGoogle Scholar
  3. [3]
    Schiffman M., Clifford G., Buonaguro F.M., Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline, Infectious Agents and Cancer, 2009, 4, 8PubMedCrossRefGoogle Scholar
  4. [4]
    Marrazzo J., Koutsky L., Kiviat N., Papanicolaou test screening and prevalence of genital human papillomavirus among women who have sex with women, Am J Public Health, 2001, 91, 947–952PubMedCrossRefGoogle Scholar
  5. [5]
    Moscicki A.B., Impact of HPV infection in adolescent populations, Journal of Adolescent Health, 2005, 37, S3–S9PubMedCrossRefGoogle Scholar
  6. [6]
    Sonnex C., Strauss S., Gray J.J., Detection of human papillomavirus DNA on the fingers of patients with genital warts, Sex Transm Inf., 1999, 75, 317–319CrossRefGoogle Scholar
  7. [7]
    Hernandez B.Y., Wilkens L.R., Zhu X., et al., Transmission of human papillomavirus in heterosexual couples, Emerging Infectious Diseases, 2008, 14(6), 888–894PubMedCrossRefGoogle Scholar
  8. [8]
    Smith J.S., Melendy A., Rana R.K., Pimenta J.M., Age-specific prevalence of infection with human papillomavirus in females: a global review, J Adolesc Health, 2008, 43(4), S5–25, S25PubMedCrossRefGoogle Scholar
  9. [9]
    Shin H.R., Franceschi S., Vaccarella S., et al., Prevalence and determinants of genital infection with papillomavirus, in female and male university students in Busan, South Korea, The Journal of Infectious Diseases, 2004, 190, 468–476PubMedCrossRefGoogle Scholar
  10. [10]
    Kliucinskas M., Nadisauskiene R.J., Minkauskiene M., Prevalence and risk factors of HPV infection among high-risk rural and urban Lithuanian women, Gynecol Obstet Invest., 2006, 62(3), 173–180PubMedCrossRefGoogle Scholar
  11. [11]
    Gudleviciene Z., Ramael M., Didziapetriene J., et al., Human papillomavirus and p53 polymorphism in Lithuanian cervical carcinoma patients, Oncology Gynecology, 2006, 102, 530–533CrossRefGoogle Scholar
  12. [12]
    Zhang W., Xue Y., Chen M., et al., Prevalence of high-risk human papillomavirus infection in different cervical lesion among organized healthexamination women in Shanghai, China, Chinese Medical Journal, 2008, 121(16), 1578–1582PubMedGoogle Scholar
  13. [13]
    Tarkowski T.A., Koumans E.H., Sawyer M., et al., Epidemiology of human papillomavirus infection and abnormal cytologic test results in an urban adolescent population, J Infect Dis., 2004, 189, 46–50PubMedCrossRefGoogle Scholar
  14. [14]
    Stamataki P., Papazafiropoulou A., Elefsiniotis I., et al., Prevalence of HPV infection among Greek women attending a gynecological outpatient clinic, BMC Infectious Diseases, 2010, 10, 27PubMedCrossRefGoogle Scholar
  15. [15]
    Winer R., Lee S., Hughes J., et al., Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students, Am J Epidemiol., 2003, 157, 218–226PubMedCrossRefGoogle Scholar
  16. [16]
    Moscicki A., Hills N., Shiboski S., et al., Risks for incident human papillomavirus infection and lowgrade squamous intraepithelial lesion development in young females, JAMA, 2001, 285, 2995–3002PubMedCrossRefGoogle Scholar
  17. [17]
    Dunne E.F., Unger E.R., Sternberg M., et al., Prevalence of HPV infection among females in the United States, JAMA, 2007, 297(8), 813–819PubMedCrossRefGoogle Scholar
  18. [18]
    Steben M., Duarte-Franco E., Human papillomavirus infection: epidemiology and pathophysiology, Gynecologic Oncology, 2007, 107, S2–S5PubMedCrossRefGoogle Scholar
  19. [19]
    Marrazzo J., Koutsky L., Kiviat N., Papanicolaou test screening and prevalence of genital human papillomavirus among women who have sex with women, Am J Public Health, 2001, 91, 947–952PubMedCrossRefGoogle Scholar
  20. [20]
    Mammas I.N., Sourvinos G., Spandidos D.A., Human papilloma virus (HPV) infection in children and adolescents, Eur J Pediatr., 2009, 168, 267–273PubMedCrossRefGoogle Scholar
  21. [21]
    Jones V., Smith S.J., Omar H.A., Nonsexual transmission of anogenital warts in children: a retrospective analysis, ScientificWorld Journal, 2007, 7, 1896–1899PubMedGoogle Scholar
  22. [22]
    Rylander E., Ruusuvaara L., Almstromer M.V., et al., The absence of vaginal human papillomavirus 16 DNA in women who have not experienced sexual intercourse, Obstet Gynecol., 1994, 83, 735–737PubMedGoogle Scholar
  23. [23]
    Popendikyte V., Gulbinovic I., Paulauskiene V., Paulauskas D., High risk human papilloma virus detection and genotyping by multiplex PCR, Lithuanian Obstetrics and Gynecology, 2008, 4, 348–352Google Scholar
  24. [24]
    Brown D.R., Shew M.L., Qadadri B., et al., A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women, The Journal of Infectious Diseases, 2005, 191, 182–192PubMedCrossRefGoogle Scholar
  25. [25]
    Schlecht N.F., Kulaga S., Robitaille J., et al., Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia, JAMA, 2001, 286, 3106–3114PubMedCrossRefGoogle Scholar
  26. [26]
    de Sanjosé S., Diaz M., Castellsagué X., et al., Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis, Lancet Infect Dis., 2007, 7(7), 453–459PubMedCrossRefGoogle Scholar

Copyright information

© © Versita Warsaw and Springer-Verlag Berlin Heidelberg 2011

Authors and Affiliations

  • Zana Bumbuliene
    • 1
  • Jonas Alisauskas
    • 2
  • Agne Sepetiene
    • 2
  1. 1.Faculty of Medicine, Clinic of Obstetrics and GynecologyVilnius UniversityVilniusLithuania
  2. 2.Vilnius University Hospital Santariskiu KlinikosVilniusLithuania

Personalised recommendations